Methodologic barriers to addressing critical questions about tobacco and cancer prognosis

Journal of Clinical Oncology

Volumn 30, Issue 17, 2012, Pages 2030-2032

  Land, Stephanie R ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PROGNOSIS; CIGARETTE SMOKING; EDITORIAL; HUMAN; METHODOLOGY; OROPHARYNX CANCER; PRIORITY JOURNAL; SELF REPORT; TOBACCO;

CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; MALE; OROPHARYNGEAL NEOPLASMS; SMOKING;

EID: 84863956681     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.41.7402     Document Type: Editorial

References (27)

1. US Department of Health and Human Services: The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, GA, US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004
2. US Department of Health and Human Services: The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta, GA, US Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2006
3. US Department of Health and Human Services: How Tobacco Smoke Causes Disease: A Report of the Surgeon General. Atlanta, GA, US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2010
4. Viswanath K, Herbst RS, Land SR, et al: Tobacco and cancer: An American Association for Cancer Research policy statement. Cancer Res 70:3419-3430, 2010
5. Gillison ML, Zhang Q, Jordan R, et al: Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 30:2102-2111, 2012
6. Parsons A, Daley A, Begh R, et al: Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: Systematic review of observational studies with meta-analysis. BMJ 340:b5569, 2010
7. Gritz ER, Dresler C, Sarna L: Smoking, the missing drug interaction in clinical trials: Ignoring the obvious. Cancer Epidemiol Biomarkers Prev 14:2287- 2293, 2005
8. National Cancer Institute, National Institutes of Health: Grid-Enabled Measures Database. http://cancercontrol.cancer.gov/brp/gem.html
9. National Cancer Institute, National Institutes of Health: Smoking cessation and continued risk in cancer patients (PDQ): Poorer treatment response in cancer patients, 12/13/11 update. http://www.cancer.gov/cancertopics/pdq/ supportivecare/ smokingcessation/HealthProfessional/page3
10. Dresler CM: Is it more important to quit smoking than which chemotherapy is used? Lung Cancer 39:119-124, 2003
11. Godtfredsen NS, Prescott E, Osler M: Smoking reduction is associated with a reduced risk of lung cancer - A secondary publication [in Danish]. Ugeskr Laeger 168:695-697, 2006
12. Tong L, Spitz MR, Fueger JJ, et al: Lung carcinoma in former smokers. Cancer 78:1004-1010, 1996 (Pubitemid 26284865)
13. Gritz ER, Lam CY, Vidrine DJ, et al: Cancer prevention: Tobacco dependence and its treatment, in DeVita V, Lawrence T, Rosenberg S (eds): Cancer: Principles and Practice of Oncology (ed 8). Philadelphia, PA, Lippincott Williams & Williams, 2008, pp 593-608
14. National Cancer Institute, National Institutes of Health: Smoking cessation and continued risk in cancer patients (PDQ): Effects of a cancer diagnosis on quitting smoking and remaining abstinent, 12/13/11 update. http:// www.cancer.gov/cancertopics/pdq/supportivecare/smokingcessation/Health Professional/page5
15. Flanders WD, Lally CA, Zhu BP, et al: Lung cancer mortality in relation to age, duration of smoking, and daily cigarette consumption: Results from Cancer Prevention Study II. Cancer Res 63:6556-6562, 2003 (Pubitemid 37255211)
16. Freedman AN, Slattery ML, Ballard-Barbash R, et al: Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol 27:686-693, 2009
17. Bach PB, Kattan MW, Thornquist MD, et al: Variations in lung cancer risk among smokers. J Natl Cancer Inst 95:470-478, 2003 (Pubitemid 36432421)
18. Spitz MR, Etzel CJ, Dong Q, et al: An expanded risk prediction model for lung cancer. Cancer Prev Res (Phila) 1:250-254, 2008
19. Barry M, Eissenberg T, Balster RL: "Alternative" tobacco products: Implications for the public health of Virginia. http://www.vcu.edu/ idas/docs/Alternative-Tobacco- Products-White-Paper.pdf
20. Office of Applied Studies, Substance Abuse and Mental Health Services Administration: Smokeless tobacco use, initiation, and relationship to cigarette smoking: 2002 to 2007-The NSDUH report, 2009. http://oas.samhsa.gov/2k9/ smokelessTobacco/smokelessTobacco.pdf
21. McClave-Regan AK, Berkowitz J: Smokers who are also using smokeless tobacco products in the US: A national assessment of characteristics, behaviours and beliefs of 'dual users'. Tob Control 20:239-242, 2011
22. Klesges RC, Ebbert JO, Morgan GD, et al: Impact of differing definitions of dual tobacco use: Implications for studying dual use and a call for operational definitions. Nicotine Tob Res 13:523-531, 2011
23. Richardson A, Xiao H, Vallone DM: Primary and dual users of cigars and cigarettes: Profiles, tobacco use patterns and relevance to policy. Nicotine Tob Res [epub ahead of print on January 17, 2012]
24. Chapple A, Ziebland S, McPherson A: Stigma, shame, and blame experienced by patients with lung cancer: Qualitative study. BMJ 328:1470, 2004
25. Simmons VN, Litvin EB, Patel RD, et al: Patient-provider communication and perspectives on smoking cessation and relapse in the oncology setting. Patient Educ Couns 77:398-403, 2009
26. Thomsen T, Tønnesen H, Okholm M, et al: Brief smoking cessation intervention in relation to breast cancer surgery: A randomized controlled trial. Nicotine Tob Res 12:1118-1124, 2010
27. Cooley ME, Emmons KM, Haddad R, et al: Patient-reported receipt of and interest in smoking-cessation interventions after a diagnosis of cancer. Cancer 117:2961-2969, 2011